SCHEMBL29288

SCHEMBL29288

O[C@@H]1[C@H](O)CO[CH][C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28771 1.00
SCHEMBL3656651 1.00
SCHEMBL751426 1.00
SCHEMBL1501859 1.00
SCHEMBL1133698 1.00
SCHEMBL28669 1.00
SCHEMBL29450 1.00
SCHEMBL29413 1.00
Hydrogen Sulfide SCHEMBL3196748 0.97
L-Arabinose SCHEMBL7378772 0.87 THRB (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 300 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10745433-B2 Compounds for inhibiting cancer and virus TAIPEI MEDICAL UNIVERSITY (TW) 2020-08-18 US claimed
US-20190016743-A1 COMPOUNDS FOR INHIBITING CANCER AND VIRUS TAIPEI MEDICAL UNIVERSITY (TW) 2019-01-17 US claimed
EP-3402800-A1 COMPOUNDS FOR INHIBITING CANCER AND VIRUS Taipei Medical University (TW) 2018-11-21 EP claimed
WO-2017123809-A1 COMPOUNDS FOR INHIBITING CANCER AND VIRUS TAIPEI MEDICAL UNIVERSITY (TW) 2017-07-20 WO claimed
EP-1641936-B1 METHODS FOR GENOME AMPLIFICATION HUMAN GENETIC SIGNATURES PTY (AU) 2010-08-04 EP claimed
US-20030139349-A1 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use LABORATORIES FOURNIER SA (FR) 2003-07-24 US claimed
EP-1240177-B1 BENZOPHENONE ALPHA-D-GLYCOPYRANOSIDES, PREPARATION AND THERAPEUTIC USE FOURNIER LAB SA (FR) 2003-07-02 EP claimed
US-20030100515-A1 Benzophenone glycopyranosides, preparation and therapeutic use LABORATORIES FOURNIER SA (FR) 2003-05-29 US claimed
US-6545134-B1 Reacting a nucleoside with aldehyde, ketone NANOGEN RECOGNOMICS, GMBH. (DE) 2003-04-08 US claimed
US-5602239-A ERYTHROMYCIN ANTIBIOTICS TAISHO PHARMACEUTICAL CO., LTD. (JP) 1997-02-11 US claimed
EP-0682038-A1 5-O-DESOSAMINYLERYTHRONOLIDE DERIVATIVE TAISHO PHARMACEUTICAL CO. LTD (JP) 1995-11-15 EP claimed
US-5081234-A Antitumor agents BRISTOL-MYERS SQUIBB CO. (US) 1992-01-14 US claimed
EP-0455159-A1 4'-Demethylepipodophyllotoxin glycosides Bristol-Myers Squibb Company (US) 1991-11-06 EP claimed
EP-0100499-A2 Phospholipid derivatives, processes for preparation thereof and pharmaceutical composition of the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-02-15 EP claimed
EP-0007812-B1 SUGAR DERIVATIVES OF C-076 COMPOUNDS, THEIR PREPARATION AND THEIR USE AS ANTIPARASITIC AGENTS MERCK & CO. INC. (US) 1983-05-11 EP claimed
US-4248999-A ANTITUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1981-02-03 US claimed
US-4203976-A ANTHELMINTICS, INSECTICIDES, PARASITICIDES, MITICIDES MERCK & CO., INC. (US) 1980-05-20 US claimed
EP-0007812-A1 Sugar derivatives of C-076 compounds, their preparation and their use as antiparasitic agents MERCK & CO. INC. (US) 1980-02-06 EP claimed
US-4156720-A Carbohydrate derivatives of milbemycin and processes therefor MERCK & CO., INC. (US) 1979-05-29 US claimed
US-4134973-A ANTIBIOTICS, PARASITICIDES MERCK & CO., INC. (US) 1979-01-16 US claimed